Abilify is a powerful antipsychotic drug that is sometimes prescribed "off-label" for anxiety and insomnia. It also increases the risk of gambling addiction and uncontrollable urges to eat, shop, or have sex.
Abilify is an anti-psychotic medication that is made and sold by Otsuka Pharmaceutical and Bristol Myers Squibb. There are now around 200 lawsuits involving people who developed gambling addictions or uncontrollable urges to eat, shop, and have sex after taking...
The label on Abilify in Canada and Europe warned about uncontrollable urges to gamble and have sex as early as 2012 — but Americans were not warned until last year.
A woman who lost over $10,000 in a 4-month gambling spree while taking the medication Abilify has filed a lawsuit against Bristol-Myers Squibb for failing to warn about the risk.
A woman who became addicted to gambling and shopping after taking Abilify (aripiprazole) has filed a lawsuit against Bristol-Myer Squibb for downplaying the risk, joining nearly 200 other lawsuits nationwide.
Bristol-Myers Squibb has agreed to pay $19.5 million to resolve allegations that the company made misleading representations to promote its blockbuster antipsychotic drug Abilify (generic: aripiprazole).
The new label will warn that patients on Abilify may not realize compulsive behaviors are unusual. Doctors should specifically ask about any new or intense urges to gamble, shop, eat, or have sex.